Overview
Stem cell transplant is sometimes used to treat people with leukemia. The majority of people with leukemia who undergo stem cell transplant receive an allogeneic stem cell transplant (allo-SCT), which means that…

Overview
Arranon is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat T-cell acute lymphoblastic leukemia (ALL) and T-cell lymphoblastic lymphoma (T-LBL). Arranon is indicated in…

Overview
Arzerra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (SLL/CLL). Arzerra is often prescribed in combination with Cytoxan, Leukeran, or…

Overview
Asparlas is a prescription drug approved by the Food and Drug Administration (FDA) to treat children and young adults up to 21 years old with acute lymphoblastic leukemia (ALL). Asparlas is also referred to by…

Overview
Aucatzyl approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). To be eligible, a person must have…

Overview
Stem cell transplant is sometimes used to treat people with leukemia. The majority of people with leukemia who undergo stem cell transplant receive an allogeneic stem cell transplant, which means that the stem…

Overview
Besponsa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory cases of B-cell precursor acute lymphoblastic leukemia (ALL) in adults. Besponsa is also…

Overview
Blincyto is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory cases of B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children…

Overview
Leukemia treatments including chemotherapy and radiation therapy can destroy bone marrow, making it impossible produce new blood cells. In people with some types of leukemia, cancer cells can damage the bone…

Overview
Bosulif is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myelogenous leukemia (CML) that have tested positive for the Philadelphia chromosome (Ph+)…

Overview
Brukinsa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL); Waldenström’s macroglobulinemia…

Overview
Busulfan is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic myelogenous leukemia (CML). Busulfan is often combined with other drugs such as Cytoxan and Fludara…

Overview
Calquence is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with chronic lymphocytic leukemia (CLL), a type of leukemia (cancer of the blood and bone marrow). People with CLL…

Overview
Campath is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat B-cell chronic lymphocytic leukemia (B-CLL). Campath may also be prescribed off-label to treat B-cell…

Overview
Chemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells. Some doctors may refer to all medication prescribed for someone with leukemia as chemotherapy. Chemotherapy is…

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for leukemia. Clinical trials are the only way that new treatments for leukemia can be tested…

Overview
Clolar is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia (ALL) in children and young adults up to the age of 21. Clolar is indicated in…

Overview
Copiktra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL) in adults…

Overview
Corticosteroids are a class of prescription drugs approved by the Food and Drug Administration (FDA) to treat inflammation. Corticosteroids are sometimes used to treat people with leukemia
The most common…

Overview
Cytarabine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating several types of leukemia including acute lymphocytic leukemia, acute myeloid leukemia, and chronic…

Overview
Dacogen is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with myelodysplastic syndromes (MDS). Dacogen is also referred to by its drug name, decitabine
Dacogen is…

Overview
Danziten is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML) in both newly diagnosed and…

Overview
Daurismo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in people 75 or older and those who cannot undergo intensive chemotherapy. Daurismo…

Overview
Erwinaze is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia in individuals who are hypersensitive to asparaginase derived from E. coli…

Overview
People who currently have or have had leukemia and other cancers are at greater risk for severe infections and serious complications from influenza (the flu) and pneumonia
The U.S. Centers for Disease Control…

Overview
Fludara is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with B-cell chronic lymphocytic leukemia (CLL). Fludara is often prescribed in combination with other…

Overview
Fludarabine phosphate is approved by the U.S. Food and Drug Administration (FDA) as part of a combination regimen for treating adults with B-cell chronic lymphocytic leukemia (CLL). It is also approved for adults…

Overview
Gazyva is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat previously untreated chronic lymphocytic leukemia (CLL) and certain types of follicular lymphoma. Gazyva is often…

Overview
Gleevec is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children with chronic myeloid leukemia (CML) that has tested positive for the Philadelphia chromosome…

Overview
Hydroxyurea is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic myeloid leukemia as well as specific types of squamous cell carcinomas in combination with…

Overview
Iclusig is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with chronic myelogenous leukemia (CML) in any phase that is positive for the Philadelphia chromosome (Ph+), in…

Overview

Idamycin PFS is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in adults. Idamycin PFS is often combined with other drugs such as…

Overview
Idhifa is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory acute myeloid leukemia (AML) that has tested positive for a mutation in the isocitrate…

Overview
Imbruvica is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and several types of non-Hodgkin lymphoma. Imbruvica is also approved to…

Overview
Imkeldi is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of leukemia. This includes newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML) in…

Overview
In some cases of chronic lymphocytic leukemia (CLL), cancerous versions of white blood cells known as plasma B cells proliferate, crowding out normal cells. Healthy plasma cells secrete proteins called…

Overview
Jaypirca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma. Jaypirca…

Overview
Komzifti is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) that carries a susceptible nucleophosmin 1 (NPM1) mutation…

Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat B-cell precursor acute lymphoblastic leukemia (ALL) in people up to age 25. It is also approved for some types of…

Overview
In some types of leukemia – most often acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) – white blood cells are greatly overproduced, causing a condition known as hyperleukocytosis. In…

Overview
Leukeran is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, lymphosarcoma, and giant follicular lymphoma. Leukeran…

Overview
Leustatin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with hairy cell leukemia. Leustatin is sometimes used off-label to treat acute myeloid leukemia (AML) and…

Overview
Lumoxiti is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory hairy cell leukemia. Lumoxiti is indicated in cases where two prior…

Overview
Marqibo is a prescription medication approved by the U.S. food and drug administration (FDA) used to treat adults with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL). Marqibo is…

Overview
Mustargen is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL), chronic myelocytic leukemia (CML), mycosis fungoides, lymphosarcoma…

Overview
Mylotarg is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat newly diagnosed adults with CD33 positive acute myeloid leukemia (AML) and adults and children with relapsed or…